Extranodal NK-T-cell lymphoma staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:
==Staging==
==Staging==


* Extranodal NK/T cell lymphoma survival rate is not well predicted by [[Ann Arbor staging system]].
* Extranodal NK/T cell lymphoma survival rate is not well predicted by [[Ann Arbor staging system]]<ref name="pmid12876666">{{cite journal| author=Jaffe ES, Krenacs L, Raffeld M| title=Classification of cytotoxic T-cell and natural killer cell lymphomas. | journal=Semin Hematol | year= 2003 | volume= 40 | issue= 3 | pages= 175-84 | pmid=12876666 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12876666  }}</ref>.
*A new system was introduced by a Korean study based on [[B symptoms]], [[Ann Arbor Staging|Ann Arbor system]], [[LDH]] level, and regional [[lymphadenopathy]] combined.Four risk groups identified as below:
*A new system was introduced by a Korean study based on [[B symptoms]], [[Ann Arbor Staging|Ann Arbor system]], [[LDH]] level, and regional [[lymphadenopathy]] combined.Four risk groups identified as below:


Line 37: Line 37:
|}
|}


* Another parallel mechanism for extranodal NK/T cell lymphoma is based on [[tumor]] [[Biology|biologic]] and micro-environmental factors. High Ki-67 [[nuclear]] antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk.<ref name="pmid24642368">{{cite journal |vauthors=Huang X, Sun Q, Fu H, Zhou X, Guan X, Wang J |title=Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China |journal=Pathol. Res. Pract. |volume=210 |issue=6 |pages=351–6 |date=June 2014 |pmid=24642368 |doi=10.1016/j.prp.2014.02.004 |url=}}</ref>
* Another parallel mechanism for extranodal NK/T cell lymphoma is based on [[tumor]] [[Biology|biologic]] and micro-environmental factors. High Ki-67 [[nuclear]] antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk.


==References==
==References==

Revision as of 13:54, 2 October 2019

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma staging

CDC on Extranodal NK-T-cell lymphoma staging

Extranodal NK-T-cell lymphoma staging in the news

Blogs on Extranodal NK-T-cell lymphoma staging

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Extranodal NK/T cell lymphoma survival rate is not well predicted by Ann Arbor staging system. A new system was introduced based on B symptoms, Ann Arbor system, LDH level, and regional lymphadenopathy combined. Another parallel mechanism for extranodal NK/T cell lymphoma is based on tumor biologic and micro-environmental factors. High Ki-67 nuclear antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk.

Staging

  1. group 1: No adverse factor
  2. group 2: One factor
  3. group 3: Two factors
  4. group 4: Three or more factors
Extranodal NK-T-cell lymphoma staging
Group Altered factors count 5 year prognosis
1 N.O. 81000 out of 100000
2 1 64000 out of 100000
3 2 34000 out of 100000
4 3/More 7000 out of 100000
  • Another parallel mechanism for extranodal NK/T cell lymphoma is based on tumor biologic and micro-environmental factors. High Ki-67 nuclear antigen is a marker for actively proliferation tumor cell which could be a related factor with mass bulk.

References


Template:WikiDoc Sources

  1. Jaffe ES, Krenacs L, Raffeld M (2003). "Classification of cytotoxic T-cell and natural killer cell lymphomas". Semin Hematol. 40 (3): 175–84. PMID 12876666.